Uptravi Beneficial Regardless of When Started, But More Effective if Started Early, Analysis Suggests
Medical Health News,
A new analysis of Actelion‘s GRIPHON clinical trial indicates that Uptravi (selexipag) tablets reduce the risk of disease…
A new analysis of Actelion‘s GRIPHON clinical trial indicates that Uptravi (selexipag) tablets reduce the risk of disease…
DALLAS -- Early treatment with triple combination therapy that included intravenous/subcutaneous prostacyclin and two oral…
Summary I have been short UTHR for some time now, and it has worked well. I still see 20% downside, perhaps more as we witness…
Actelion announced that one of its lead products, Uptravi (selexipag), designed for the treatment of pulmonary arterial…